Orchestra BioMed Inc. (OBIO)
NASDAQ: OBIO
· Real-Time Price · USD
2.63
0.06 (2.53%)
At close: Aug 18, 2025, 3:59 PM
2.67
1.33%
After-hours: Aug 18, 2025, 07:43 PM EDT
2.53% (1D)
| Bid | 2.65 |
| Market Cap | 142.17M |
| Revenue (ttm) | 2.89M |
| Net Income (ttm) | -66.32M |
| EPS (ttm) | -1.83 |
| PE Ratio (ttm) | -1.44 |
| Forward PE | -1.53 |
| Analyst | Buy |
| Ask | 2.8 |
| Volume | 343,986 |
| Avg. Volume (20D) | 315,316 |
| Open | 2.59 |
| Previous Close | 2.56 |
| Day's Range | 2.56 - 2.66 |
| 52-Week Range | 2.37 - 7.04 |
| Beta | 0.61 |
About OBIO
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol OBIO
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for OBIO stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsEarnings Surprise
Orchestra BioMed has released their quartely earnings
on Aug 12, 2025:
Next Earnings Release
Orchestra BioMed Inc. is scheduled to release its earnings on
Nov 11, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
2 weeks ago
-20.26%
Orchestra BioMed Holdings shares are trading lower...
Unlock content with
Pro Subscription
2 weeks ago
-1.92%
Orchestra BioMed Holdings shares are trading lower after the company announced a proposed public offering.
2 months ago · seekingalpha.com
Orchestra BioMed: Two Best-In-Class Devices And Promising PartnershipsOrchestra BioMed holds two best-in-class medical device therapies targeting large markets, with strong partnerships and equity investments from Medtronic and Terumo. Both AVIM Therapy and Virtue SAB h...